Category: Philips HealthcareSyndicate content

Appeals court denies Zoll challenge to Philips AED patents

August 28, 2014 by Brad Perriello

A federal appeals court upholds the U.S. Patent & Trademark Office's decision not to review 8 defibrillator patents owned by Philips Healthcare and dismisses the case.

Appeals court denies Zoll challenge to 8 Philips patents

FDA grants Philips clearance for 3D TAVI software | Regulatory news for the week of August 25, 2014

August 26, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Philips wins FDA nod for 3D TAVI planning software; Direct Flow wins CE Marks for TAVI device; FDA OKs return of Covidien's Pipeline embolism device; FDA delays UDI rule for contacts, intraocular lenses; Cardiovascular Systems recalls some Diamondback devices on embolism risk

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Philips wins FDA nod for 3D TAVI planning software

August 21, 2014 by Brad Perriello

Philips Healthcare wins 510(k) clearance from the FDA for its 3D planning software for transcatheter aortic valve implants.

Philips wins FDA nod for 3D TAVI planning software

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Dentsply, Philips Healthcare land $39M in Pentagon deals

August 15, 2014 by Brad Perriello

Dentsply and Philips Healthcare land contracts worth a collective $39 million from the U.S. Defense Dept.

Dentsply, Philips Healthcare land $39M in Pentagon deals

Zoll Medical, Philips withdraw appeal in defibrillator patent spat

August 13, 2014 by Brad Perriello

Zoll Medical and Philips Healthcare add a chapter to their 4-year-old battle over automated external defibrillator technology, withdrawing the appeal of Zoll's April loss in the patent infringement war.

Zoll Medical, Philips withdraw appeal in defibrillator patent spat

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014

July 31, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Smith & Nephew CEO reveals new 'no frills' strategy; Bard: We're on track for early 2015 Lutonix approval; Ocular Therapeutix prices IPO below range; Philips' healthcare business suffers in Q2; Intersect ENT prices IPO at low end of range

Smith & Nephew CEO reveals new 'no frills' strategy

July 28, 2014 by Brad Perriello

Philips' healthcare business suffers in Q2

July 28, 2014 by Arezu Sarvestani

Sluggish healthcare sales drag down Philips overall figures, but the company is eying a comeback for the 2nd half of the year.

Philips' healthcare business suffers in Q2

Philips Healthcare (NYSE:PHG) had a tough 2nd quarter with a shutdown of a manufacturing facility in Cleveland taking some of the wind out of the sales for the entire company.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp